(Q39361870)

11 September 2017

title

Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis (English)

1 reference

11 September 2017

1 reference

15

Judy Lieberman

1 reference

11 September 2017

Yan-dan Yao

1

1 reference

11 September 2017

Tian-meng Sun

2

1 reference

11 September 2017

Song-yin Huang

3

1 reference

11 September 2017

Shuang Dou

4

1 reference

11 September 2017

Ling Lin

5

1 reference

11 September 2017

Jia-ning Chen

6

1 reference

11 September 2017

Jian-bin Ruan

7

1 reference

11 September 2017

Cheng-qiong Mao

8

1 reference

11 September 2017

Feng-yan Yu

9

1 reference

11 September 2017

Mu-sheng Zeng

10

1 reference

11 September 2017

Jian-ye Zang

11

1 reference

11 September 2017

Qiang Liu

12

1 reference

11 September 2017

Feng-xi Su

13

1 reference

11 September 2017

Peter Zhang

14

1 reference

11 September 2017

Jun Wang

16

1 reference

11 September 2017

Erwei Song

17

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

Science Translational Medicine

11 September 2017

published in

1 reference

11 September 2017

volume

4

1 reference

11 September 2017

issue

130

1 reference

11 September 2017

page(s)

130ra48

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Evolving novel anti-HER2 strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Polo-like kinases and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Polo-like kinases and the orchestration of cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Targeting Polo-like kinase in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Structural basis for RNA-silencing suppression by Tomato aspermy virus protein 2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Assessment of siRNA pharmacokinetics using ELISA-based quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Prospects of RNA interference therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Nonviral methods for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Future prospect of RNA interference for cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Concepts in in vivo siRNA delivery for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

siRNA delivery systems for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Therapeutic potential of RNA interference against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Short interfering RNA (siRNA) as a novel therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Intracellular antibodies (intrabodies) and their therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Activation of the interferon system by short-interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

Low molecular weight protamine: a potent but nontoxic antagonist to heparin/low molecular weight protamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003601

10.1126/SCITRANSLMED.3003601

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference